ResMed Inc. ResMed Inc.

ResMed Inc.

RMD

Rankning i aktier #720
ResMed Inc. is a leading global medical technology enterprise engaged in the... ResMed Inc. is a leading global medical technology enterprise engaged in the creation, production, distribution, and marketing of healthcare devices and connected digital solutions. The company operates through two primary segments: Sleep and Respiratory Care, and Software as a Service. Its extensive product range addresses a variety of respiratory disorders, encompassing advanced medical and consumer technologies, ventilation devices, diagnostic equipment, mask systems for both clinical and personal use, headgear, and related accessories, alongside dental devices. ResMed also provides sophisticated cloud-based informatics to enhance patient management and operational efficiency. Notable software offerings in its respiratory portfolio include AirView, for remote device monitoring and setting adjustments; myAir, a personalized application designed to support sleep apnea patients with education and troubleshooting for better engagement and adherence; and U-Sleep, a compliance tracking platform for home medical equipment providers. Complementing these are connectivity modules and Propeller solutions. Furthermore, ResMed offers a robust suite of out-of-hospital software. This includes Brightree, a business management platform for various home care service providers (e.g., HME, pharmacy, infusion, orthotics, prosthetics); MatrixCare, providing care management for senior living, skilled nursing, and hospice organizations; and HEALTHCAREfirst, which supplies electronic health records, billing, coding services, and analytics for home health and hospice agencies. ResMed distributes its offerings primarily to sleep clinics, home healthcare dealers, and hospitals via a global network of distributors and a direct sales force, serving approximately 140 countries. Founded in 1989, the company's headquarters are located in San Diego, California.
Aktiekurs
$239.38
Marknadsvärde
$33.67B
Förändring (1 dag)
0.38%
Förändring (1 år)
-10.71%
Land
US
Handel ResMed Inc. (RMD)

Kategori

Healthcare
Rörelsemarginal för ResMed Inc. (RMD)
Rörelsemarginal per October 2026 TTM: 33.48%
Enligt de senaste finansiella rapporterna och aktiekursen för ResMed Inc. är företagets nuvarande rörelsemarginal (TTM) 33.48%. Vid slutet av 2024 var rörelsemarginalen 28.17%.
Historik för rörelsemarginal för ResMed Inc. från 2000 till 2026
Rörelsemarginal vid slutet av varje år
År Rörelsemarginal Ändra
2026 (TTM) 33.48% 2.23%
2025 32.75% 16.26%
2024 28.17% 5.11%
2023 26.80% -4.15%
2022 27.96% -1.10%
2021 28.27% 3.25%
2020 27.38% 23.22%
2019 22.22% -4.02%
2018 23.15% 12.38%
2017 20.60% -11.70%
2016 23.33% -4.31%
2015 24.38% -6.41%
2014 26.05% 11.18%
2013 23.43% 8.93%
2012 21.51% 0.19%
2011 21.47% -2.45%
2010 22.01% 6.48%
2009 20.67% 20.81%
2008 17.11% 35.90%
2007 12.59% -41.79%
2006 21.63% -5.46%
2005 22.88% -9.06%
2004 25.16% 2.36%
2003 24.58% -198.05%
2002 -25.07% -249.40%
2001 16.78% -41.45%
2000 28.66% 0.00%
Rörelsemarginal för liknande företag eller konkurrenter
Företag Rörelsemarginal Skillnad i rörelsemarginal Land
17.03% -99.49%
US
17.86% -99.47%
IE
22.03% -99.34%
US
21.46% -99.36%
US
0.00% -
DE
Vad är ett företags Rörelsemarginal?
Rörelsemarginal är en viktig indikator för att bedöma ett företags lönsamhet. Högre Rörelsemarginals är generellt bättre eftersom de visar att ett företag kan sälja sina produkter eller tjänster för betydligt mer än produktionskostnaden. Rörelsemarginal beräknas genom att dividera företagets vinst med dess intäkter.